121Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC - mechanisms and evolving treatment approaches.2026 · Europe PMC
122Radiotherapy with or without chemotherapy for T2N0 hypopharyngeal cancer: an analysis of the head and neck cancer registry of Japan.2026 · Europe PMC
124Unravelling the crosstalk: Anti-fibrotic agents and MAPK inhibitors in the treatment of melanoma.2026 · Europe PMC
125Tumour-based epigenetic signatures as markers of prostate cancer aggressiveness after radical prostatectomy.2026 · Europe PMC
126Patterns of care in primary brain tumour Reirradiation: A survey by the ESTRO CNS focus Group.2026 · Europe PMC
127Dormancy in colorectal cancer: The functional core of resistance, metastasis, and relapse.2026 · Europe PMC
128Unlocking precision: Bispecific T cell engagers and the next frontier in uro-oncology.2026 · Europe PMC
129Overcoming tumour resistance in cancer immunotherapy through predictive and pharmacodynamic biomarkers.2026 · Europe PMC
130Circulating tumour DNA for a minimal residual disease assessment and recurrence risk in hepatocellular carcinoma: a systematic review and meta-analysis.2026 · Europe PMC
133Plasma fibrinogen levels towards cancer incidence: a systematic review and meta-analysis of epidemiological studies.2025 · Europe PMC
136OS05.5.A RADIAL GLIAL CELLS AS SOURCE ANTIGEN FOR ADOPTIVE CELLULAR THERAPY IN GLIOBLASTOMA2025 · Europe PMC
138Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer.2025 · Europe PMC
139Messenger RNA vaccines as adjuncts to surgical oncology: a new era in neoplasm immunotherapy and precision medicine.2025 · Europe PMC
140Peritoneal Cancer Index Dominates Prognosis After CRS-HIPEC for Colorectal Peritoneal Metastases: A Consecutive Single-Centre Cohort with 3-Year Follow-Up.2025 · Europe PMC
141Histotripsy Compared With Microwave Ablation, Radiofrequency Ablation, and Stereotactic Body Radiotherapy for the Treatment of Liver Tumors.2025 · Europe PMC
142Regulatory mechanisms and therapeutic targeting of metastatic tumor dormancy in colorectal cancer: A comprehensive review.2025 · Europe PMC
143Diagnosis and management of a rare bilateral ovarian mixed germ cell tumor: a case report.2025 · Europe PMC
144Pituitary Gland Metastases As the Initial Presentation of Lung Adenocarcinoma: A Case Report.2025 · Europe PMC
145Scientific and regulatory progress in advancing paediatric oncology drug development in the EU and in the US.2025 · Europe PMC
146Safety evaluation of selective estrogen receptor degraders (SERDs) using real-world evidence from the FDA Adverse Event Reporting System (FAERS).2025 · Europe PMC
147Impact of robotic and non-robotic approach on spread through air spaces in early-stage lung cancer.2025 · Europe PMC
148Characteristics of <i>KRAS</i> WT pancreatic adenocarcinomas: results of a large French multicentric cohort.2025 · Europe PMC
149Clinical Features and Outcomes of Locally Advanced and Metastatic Basal Cell Carcinoma.2025 · Europe PMC
150Tumour and adipose tissue uptake on <sup>18</sup>F-Fluorodeoxyglucose (<sup>18</sup>F-FDG) positron emission tomography/computed tomography (PET/CT) predict immunotherapy response in recurrent or metastatic nasopharyngeal carcinoma.2025 · Europe PMC
151Timely and Accurate Diagnosis of Rare Metastatic Melanoma With Pulmonary Vascular, Cardiac, and Brain Involvement: Improving Diagnostic Access and Minimising Risk.2025 · Europe PMC
152A rare case of primary transverse colon adenocarcinoma penetrating the abdominal wall.2025 · Europe PMC
153Patterns in genomic mutations among patients with early-onset colorectal cancer: an international, multicohort, observational study.2025 · Europe PMC
154Innovative insights into gut microbiota modulation in colorectal cancer: From microbial dysbiosis to therapeutic strategies.2025 · Europe PMC
156Metformin and its derivatives in breast cancer: from glycaemic control to tumor-intrinsic pathways.2025 · Europe PMC
157Psychiatric Comorbidity, Functional Status, and Neuroinflammatory Pathways in Cancer Patients with and Without Type 2 Diabetes.2025 · Europe PMC
158Clinicopathological significance and prognostic analysis of p21 and EGFR in colorectal cancer: a retrospective analysis on 12 319 cases in China.2025 · Europe PMC
159Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial.2025 · Europe PMC
162Synchronous Breast and Kidney Carcinomas Following Treatment for Hodgkin's Lymphoma in Young Adulthood: A Case Report and Literature Review.2025 · Europe PMC
163P2RX4 promotes hepatocellular carcinoma progression via calcium-mediated PI3K/AKT activation and immune remodeling.2025 · Europe PMC
164Identification of key genes in pancreatic ductal adenocarcinoma with biologically informed deep neural network.2025 · Europe PMC
165Virtual CNS Tumor Board Rounds Within the Canadian Adolescent and Young Adult Neuro-Oncology Network.2025 · Europe PMC
166SGLT2 inhibitors and their role in reducing mortality among cancer patients with type 2 diabetes undergoing immune checkpoint inhibitor therapy.2025 · Europe PMC
167A novel hybrid approach for multi stage kidney cancer diagnosis using RCC ProbNet.2025 · Europe PMC
168Evaluation of Carcinoembryonic Antigen as a Prognostic Marker for Colorectal Cancer Relapse: Insights from Postoperative Surveillance.2025 · Europe PMC
169Guidelines for Clinicians and Pathologists on Performing Skin Biopsies and Reporting on Suspected Cutaneous Squamous Cell Carcinoma.2025 · Europe PMC
171Unraveling the role of perineural invasion in cancer progression across multiple tumor types.2025 · Europe PMC
172Role of radiotherapy in the management of anal canal cancer: Recommendations of the Société française de radiothérapie oncologique.2025 · Europe PMC
173Advances in Radiotherapy and Chemoradiotherapy for the Treatment of Gastric Cancer (2014-2023): A Scientometric Approach.2025 · Europe PMC
174Association between olanzapine and immune function in lung cancer patients with anxiety and depression: a retrospective cohort study of medical records.2025 · Europe PMC
175P02.24.A MOLECULAR AND MORPHOLOGICAL FEATURES OF BLOOD VESSELS IN TUMOUR MARGIN REGIONS OF GLIOBLASTOMA ARE DISTINCT FROM TUMOUR CORE AND NORMAL BRAIN, AND DRUG DELIVERY IS REDUCED2025 · Europe PMC
176Disseminated pediatric low-grade glioma and hydrocephalus: a multinational consortium analysis of incidence and mortality.2025 · Europe PMC
178Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design.2025 · Europe PMC
179Identification of a novel <i>PRUNE2::NTRK2</i> gene fusion in soft tissue sarcoma patients-friend or foe? Case series.2025 · Europe PMC
180Primary malignant peripheral nerve sheath tumour of the lung: incidental detection on chest imaging performed for unrelated trauma.2025 · Europe PMC